Key result
Urinary RAAS biomarkers exhibit high daily variability and vary significantly by urine collection method.
Why the study?
Dysregulation of the RAAS is associated with cardiovascular and renal disease, motivating evaluation of daily variability in urinary RAAS biomarkers and differences between non-sedated free catch and sedated cystocentesis samples in vervet monkeys.
Does urine collection via sedated cystocentesis alter urinary renin-angiotensin-aldosterone system (RAAS) biomarker concentrations and day-to-day variability compared to non-sedated free catch collection in healthy adult vervet monkeys?
Does urine collection via sedated cystocentesis alter urinary renin-angiotensin-aldosterone system (RAAS) biomarker concentrations and day-to-day variability compared to non-sedated free catch collection in healthy adult vervet monkeys?
Substantial day-to-day variability and significant differences between non-sedated free catch and sedated cystocentesis samples demonstrate that single-timepoint urinary RAAS measurements are insufficient in nonhuman primate models and require standardized collection protocols with repeated sampling.
Answers are grounded in this paper and cite their sources.
High variability and collection differences caution against single urinary RAAS measurements in primate models; leaves open standardized repeated sampling for translational research.
BACKGROUND: Dysregulation of the renin-angiotensin-aldosterone system (RAAS) is associated with cardiovascular and renal disease. Our objectives were to determine the daily variability in urinary RAAS biomarkers and differences between non-sedated free catch (FC) and sedated cystocentesis samples in vervet monkeys. METHODS: We performed repeated urine collections (six non-sedated FC, three sedated cystocentesis) from six adult vervets (Chlorocebus aethiops sabaeus). We quantified RAAS components, normalized to urine creatinine. We assessed variability using coefficients of variation (CV) and compared sedation effects using linear mixed-effects models with false discovery rate correction. RESULTS: Analytes showed high to very high variability (CV 28.17%-103.03%). Angiotensin converting enzyme demonstrated the lowest variability (cystocentesis, CV 28.17% ± 18.28%). Creatinine, Angiotensin-(1-7), Angiotensin II, and aldosterone concentrations differed between non-sedated FC and sedated cystocentesis samples. CONCLUSIONS: Substantial within-animal variability suggests that single-timepoint measurements insufficiently characterize urinary RAAS in vervets. Differences between collection conditions support standardization of collection methods and repeated sampling.
No takes yet. Share an insight, caveat, or question.
Graham et al. (2026) studied Healthy adult vervet monkeys (Chlorocebus aethiops sabaeus) (n=6). Sedated cystocentesis urine collection (intramuscular ketamine and inhaled isoflurane) vs. Non-sedated free catch (FC) urine collection was evaluated on Day-to-day variability (coefficient of variation, CV) and concentration differences in creatinine-normalized urinary RAAS biomarkers (ACE, ACE2, Ang-(1-7), Ang II, aldosterone, alpha-klotho) and urine creatinine (p=0.044). Urinary RAAS biomarkers in vervet monkeys showed high daily variability and differed between sedated cystocentesis and free catch samples.
Synapse has enriched 10 related papers. Consider them for comparative context: